Form 4 for DERM Journey Medical Corp
Accepted 2026-04-24 17:28:53 ET · period of report 2026-04-22 · accession 0001104659-26-048733 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-24 17:28 | 2026-04-22 | DERM | Benesch Joseph | CFO | A - Grant | $0.00 | +28.9K | 261.4K | +12% | $0 |
| D | 2026-04-24 17:28 | 2026-04-22 | DERM | Benesch Joseph | CFO | A - Grant | $0.00 | +41.9K | 41.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2026-04-22 | A | A | 28,907 | $0.00 | 261,371 | D | — | — | (F1) On April 22, 2026, the reporting person was granted 28,907 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 9,636 shares on April 22, 2027, 9,636 shares on April 22, 2028 and 9,635 shares on April 22, 2029. (F2) Includes restricted stock units, which vest over various time periods. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | A | A | 41,860 | $0.00 | 41,860 | D | $5.04 · — to 2036-04-22 | 41,860 Common Stock, $0.0001 par value | (F3) On April 22, 2026, the reporting person was granted 41,860 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 13,953 shares on April 22, 2027, 13,953 shares on April 22, 2028 and 13,954 shares on April 22, 2029. |